⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
NKTR
NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit
prnewswire.com
NKTR
Class Action Filing Initiated by Pomerantz LLP Concerning Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR FINAL DEADLINE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR
accessnewswire.com
NKTR
Class Action Filed by Pomerantz LLP Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
Class Action Filing Initiated by Pomerantz LLP Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
Class Action by Pomerantz LLP Filed Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
Class Action Filing Announced by Pomerantz LLP Concerning Nektar Therapeutics – NKTR
accessnewswire.com
NKTR